FARALLON CAPITAL MANAGEMENT, L.L.C. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0000909661
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Tom Steyer — tracked via quarterly SEC 13F filings · All famous investors
Q3 2026 · 109 positions · Total reported value $22.58B · Top-10 concentration 62.3% · Updated 2026-11-16
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
Turnover: 64.4% · 43 new · 19 cut · 23 exited
Active Share (vs S&P 500): 91.2% · vs QQQ: 92.5% — share of the book that differs from index weights (higher = more active) · ranking
In its Q3 2026 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. disclosed 109 equity positions with a combined reported value of $22.58B. The filing implies a focused portfolio: its ten largest positions account for 62.3% of reported value. HoldingsHub classifies the profile as Large / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q3 2026 were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B). By sector, the heaviest allocations are Health Care 51.5%, Communication Services 9.6%. Versus the prior quarter, allocation shifted toward Communication Services (+6.3pp), Health Care (+3.3pp) and away from Other (-11.2pp).
Versus the prior quarter, FARALLON CAPITAL MANAGEMENT, L.L.C. opened 43 new positions, trimmed 19 and fully exited 23, a turnover rate of 64.4% of positions. The portfolio's overlap with the prior quarter was 50% of names.
The largest new positions opened in Q3 2026 were ROKU ($633.49M), CRH ($442.24M), IONI ($57.69M).
Of the 23 positions fully exited versus the prior quarter, the largest were EA ($1.62B), CRNX ($336.37M), APGE ($140.69M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2026)
Fully Exited (vs previous quarter)
- EA ELECTRONIC ARTS INC · prev qtr: $1.62B
- CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $336.37M
- APGE APOGEE THERAPEUTICS INC · prev qtr: $140.69M
- NVO NOVO-NORDISK A S · prev qtr: $125.55M
- SOXX ISHARES TR · prev qtr: $83.30M
- CGON CG ONCOLOGY INC · prev qtr: $28.42M
- MRK MERCK & CO INC · prev qtr: $25.57M
- WRBY WARBY PARKER INC · prev qtr: $25.12M
Insider Transactions (Form 4)
Latest Tom Steyer buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Farallon Capital Management is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 86 US equity positions with a combined value of $21.54B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: SAN FRANCISCO, CA, United States
- SEC registration: 801-51763 (status: Approved), registered 1996-04-01
- Regulatory AUM (Form ADV): $52.08B as of 2026-09-23
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 50 private funds, of which 50 hedge funds
- Website: faralloncapital.com
Portfolio Structure
- 86 positions · $21.54B reported value (Q2 2026)
- Top 10 holdings = 62.5% of reported value
- Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 20.8%
- Average position size: $250.46M
Sector Tilt
- Health Care 51.2%
- Information Technology 6.7%
- Consumer Discretionary 4.0%
- (classified holdings cover 70% of value)
Quarterly Activity
- Q2 2026: 20 new, 29 added, 23 reduced, 103 exited
- 14 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
AI Rebalance Analysis
Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-17 03:47
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.22M | $3.98B | 17.63% | Reduce | |
| 2 |
|
13.42M | $2.75B | 12.20% | Reduce | |
| 3 |
|
49.37M | $1.53B | 6.77% | Add | |
| 4 |
|
2.60M | $1.07B | 4.76% | Add | |
| 5 |
|
14.25M | $937.45M | 4.15% | Add | |
| 6 |
|
6.44M | $907.04M | 4.02% | Add | |
| 7 |
|
14.69M | $858.33M | 3.80% | Add | |
| 8 |
|
21.75M | $795.23M | 3.52% | Add | |
| 9 |
|
4.16M | $633.49M | 2.81% | New | |
| 10 |
|
2.37M | $590.10M | 2.61% | Reduce | |
| 11 |
|
4.07M | $570.18M | 2.52% | Reduce | |
| 12 |
|
11.29M | $492.68M | 2.18% | Add | |
| 13 |
|
1.40M | $490.19M | 2.17% | Add | |
| 14 |
|
5.34M | $442.24M | 1.96% | New | |
| 15 |
|
25.02M | $441.76M | 1.96% | Hold | |
| 16 |
|
2.14M | $412.84M | 1.83% | Hold | |
| 17 |
|
1.05M | $384.93M | 1.71% | Reduce | |
| 18 |
|
733.56K | $376.24M | 1.67% | Reduce | |
| 19 |
|
857.89K | $373.13M | 1.65% | Add | |
| 20 |
|
3.88M | $354.25M | 1.57% | Reduce | |
| 21 |
|
1.24M | $343.10M | 1.52% | Reduce | |
| 22 |
|
3.11M | $309.66M | 1.37% | Reduce | |
| 23 |
|
445.69K | $300.86M | 1.33% | Reduce | |
| 24 |
|
8.91M | $269.50M | 1.19% | Add | |
| 25 |
|
877.90K | $252.12M | 1.12% | Reduce | |
| 26 |
|
10.28M | $251.26M | 1.11% | Hold | |
| 27 |
|
4.61M | $246.67M | 1.09% | Add | |
| 28 |
|
6.47M | $218.59M | 0.97% | Add | |
| 29 |
|
5.94M | $197.49M | 0.88% | Hold | |
| 30 |
|
680.87K | $153.79M | 0.68% | Add | |
| 31 |
|
480.43K | $127.19M | 0.56% | Add | |
| 32 |
|
4.61M | $126.73M | 0.56% | Add | |
| 33 |
|
2.04M | $115.99M | 0.51% | Add | |
| 34 |
|
4.55M | $113.54M | 0.50% | Reduce | |
| 35 |
|
1.20M | $104.57M | 0.46% | Hold | |
| 36 |
|
2.37M | $76.47M | 0.34% | Hold | |
| 37 |
|
440.00K | $71.05M | 0.32% | Reduce | |
| 38 |
|
820.20K | $65.82M | 0.29% | Add | |
| 39 |
|
3.97M | $60.92M | 0.27% | Add | |
| 40 |
|
718.12K | $57.69M | 0.26% | New | |
| 41 |
|
279.70K | $49.89M | 0.22% | Reduce | |
| 42 |
|
47.63M | $45.13M | 0.20% | Add | |
| 43 |
|
916.80K | $43.40M | 0.19% | New | |
| 44 |
|
1.60M | $37.69M | 0.17% | Hold | |
| 45 |
|
255.00K | $36.36M | 0.16% | Reduce | |
| 46 |
|
1.11M | $30.11M | 0.13% | Hold | |
| 47 |
|
741.41K | $28.46M | 0.13% | New | |
| 48 |
|
928.00K | $28.11M | 0.12% | New | |
| 49 |
|
13.52K | $24.49M | 0.11% | New | |
| 50 |
|
218.90K | $20.61M | 0.09% | Add | |
FAQ
What did FARALLON CAPITAL MANAGEMENT, L.L.C. buy in 2026-Q3?
In its 2026-Q3 13F filing, FARALLON CAPITAL MANAGEMENT, L.L.C. reported 109 equity positions worth $22.58B in aggregate; its largest disclosed positions were SPY ($3.98B), RVMD ($2.75B), WBD ($1.53B).
How large is FARALLON CAPITAL MANAGEMENT, L.L.C.'s portfolio?
FARALLON CAPITAL MANAGEMENT, L.L.C. reported $22.58B of long equity holdings across 109 positions as of 2026-Q3. Top-10 holdings account for 62.3% of reported value.
What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s investment style?
HoldingsHub classifies the portfolio as Large / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.